Study S001419

The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Gestational Diabetes Mellitus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT01795248
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: TRIPLE
Status: COMPLETED
Enrollment: 105
Start: 2012-07
Primary completion: 2019-09
Lead sponsor: Tina Vilsboll
Conditions: Gestational Diabetes Mellitus
Interventions: DRUG:Liraglutide; DRUG:Placebo
Results posted: FALSE
Secondary identifiers: EUDRACT_NUMBER:2012-001371-37

Registered primary outcomes

Change in glucose tolerance [from baseline to 52 wks, 53 wks, 260 wks, and 261 wks]

Linked records (5)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0016480	The effect of a glucagon-like peptide-1 receptor agonist on glucose tolerance in women with previous gestational diabetes mellitus: protocol for an investigator-initiated, randomised, placebo-controlled, double-blinded, parallel intervention trial. Foghsgaard S, BMJ open	2013	Protocol	PMID 24176797 DOI	cites ClinicalTrials.gov:NCT01795248; cites EudraCT:2012-001371-37; registry reference DERIVED:24176797
R0025439	Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. Astrup A, International journal of obesity (2005)	2012	Randomized trial	PMID 21844879 DOI	registry reference BACKGROUND:21844879
R0027293	Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Astrup A, Lancet (London, England)	2009	Randomized trial	PMID 19853906 DOI	registry reference BACKGROUND:19853906
R0027724	The physiology of glucagon-like peptide 1. Holst JJ, Physiological reviews	2007	Narrative review	PMID 17928588 DOI	registry reference BACKGROUND:17928588
R0028052	Incretins, insulin secretion and Type 2 diabetes mellitus. Vilsbøll T, Diabetologia	2004	Narrative review	PMID 14968296 DOI	registry reference BACKGROUND:14968296